Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825–883.
176.
Mariani A, Webb MJ, Keeney GL, et al. Hematogenous dissemination in corpus cancer. Gynecol Oncol 2001;80:233–238.
177.
Lutz MH, Underwood PB, Kreutner A Jr, et al. Endometrial carcinoma: a new method of classification of therapeutic and prognostic significance. Gynecol Oncol 1978;6:83–94.
178.
Kaku T, Tsuruchi N, Tsukamoto N, et al. Reassessment of myometrial invasion in endometrial carcinoma. Obstet Gynecol 1994;84: 979–982.
179.
Cowles TA, Magrina JF, Materson BJ, et al. Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstet Gynecol 1985;66:413–416.
180.
Hanson MB, Van Nagell JR, Powell DE, et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 1985;55:1753–1757.
181.
Abeler VM, Kjorstad KE, Berle E. Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population. Int J Gynecol Cancer 1992;2:9–32.
182.
Mariani A, Webb MJ, Keeney GL, et al. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 2002;84:437–442.
183.
Mariani A, Webb MJ, Galli L, et al. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 2000;76:348–356.
184.
Creasman WT, DiSaia PJ, Blessing J, et al. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 1981;141:921–929.
185.
Harouny VR, Sutton EP, Clark SA, et al. The importance of peritoneal cytology in endometrial carcinoma. Obstet Gynecol 1988;72: 394–398.
186.
Turner DA, Gershenson DM, Atkinson N, et al. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol 1989;74:775–780.
187.
Lurain JR, Rumsey NK, Schink JC, et al. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1989;74:175–179.
188.
Kadar N, Homesley HD, Malfetano JH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 1992;46:145–149.
189.